Literature DB >> 20075197

Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes.

Anil Bhanudas Gaikwad1, Sufyan G Sayyed, Julia Lichtnekert, Kulbhushan Tikoo, Hans-Joachim Anders.   

Abstract

The combination of diabetes and renal failure is associated with accelerated cardiomyopathy, but the molecular mechanisms of how renal failure drives diabetic heart disease remain elusive. We speculated that the metabolic abnormalities of renal failure will affect the epigenetic control of cardiac gene transcription and sought to determine the histone H3 modification pattern in hearts of type 2 diabetic mice with several degrees of renal dysfunction. We studied the histone H3 modifications and gene expression in the heart of 6-month-old nondiabetic mice and type 2 diabetic db/db mice that underwent either sham surgery or uninephrectomy at 6 weeks of age, which accelerates glomerulosclerosis in db/db mice via glomerular hyperfiltration. Western blotting of hearts from uninephrectomized db/db mice with glomerulosclerosis, albuminuria, and reduced glomerular filtration rate revealed increased acetylation (K23 and 9), phosphorylation (Ser 10), dimethylation (K4), and reduced dimethylation of (K9) of cardiac histone H3 as compared with db/db mice with normal renal function or nondiabetic wild-type mice. This pattern suggests alterations in chromatin structure that favor gene transcription. In fact, hearts from uninephrectomized db/db mice revealed increased mRNA expression of multiple cardiomyopathy-related genes together with cardiomyocyte hypertrophy. These data suggest that renal failure alters cardiac histone H3 epigenetics, which foster cardiomyocyte hypertrophy in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075197      PMCID: PMC2832129          DOI: 10.2353/ajpath.2010.090528

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

Review 1.  From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension.

Authors:  Ernesto L Schiffrin; Rhian M Touyz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

2.  Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide.

Authors:  Galit Hasdan; Sydney Benchetrit; Gloria Rashid; Janice Green; Jacques Bernheim; Mauro Rathaus
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

3.  Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.

Authors:  Nosratola D Vaziri; Michael Dicus; Nathan D Ho; Laleh Boroujerdi-Rad; Ram K Sindhu
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

Review 4.  Global and societal implications of the diabetes epidemic.

Authors:  P Zimmet; K G Alberti; J Shaw
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

5.  Genome-wide histone methylation profile for heart failure.

Authors:  Ruri Kaneda; Shuji Takada; Yoshihiro Yamashita; Young Lim Choi; Mutsuko Nonaka-Sarukawa; Manabu Soda; Yoshio Misawa; Tadashi Isomura; Kazuyuki Shimada; Hiroyuki Mano
Journal:  Genes Cells       Date:  2008-12-10       Impact factor: 1.891

6.  Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.

Authors:  Karanam Balasubramanyam; Radhika A Varier; Mohammed Altaf; Venkatesh Swaminathan; Nagadenahalli B Siddappa; Udaykumar Ranga; Tapas K Kundu
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

7.  Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy.

Authors:  K Tikoo; R L Meena; D G Kabra; A B Gaikwad
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

8.  Associations between circulating inflammatory markers and residual renal function in CRF patients.

Authors:  Roberto Pecoits-Filho; Olof Heimbürger; Peter Bárány; Mohamed Suliman; Ingela Fehrman-Ekholm; Bengt Lindholm; Peter Stenvinkel
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

9.  Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.

Authors:  R N Foley; P S Parfrey; J D Harnett; G M Kent; D C Murray; P E Barre
Journal:  Kidney Int       Date:  1996-05       Impact factor: 10.612

Review 10.  Cardiac histone acetylation--therapeutic opportunities abound.

Authors:  Timothy A McKinsey; Eric N Olson
Journal:  Trends Genet       Date:  2004-04       Impact factor: 11.639

View more
  28 in total

1.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 2.  Fetal environment, epigenetics, and pediatric renal disease.

Authors:  Robert Woroniecki; Anil Bhanudas Gaikwad; Katalin Susztak
Journal:  Pediatr Nephrol       Date:  2010-12-21       Impact factor: 3.714

3.  Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC).

Authors:  Chandra Sekhar Rao Kadiyala; Ling Zheng; Yunpeng Du; Elizabeth Yohannes; Hung-Ying Kao; Masaru Miyagi; Timothy S Kern
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

Review 4.  Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.

Authors:  Beatriz Suárez-Álvarez; Helen Liapis; Hans-Joachim Anders
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

5.  Exploring the mitochondrial microRNA import pathway through Polynucleotide Phosphorylase (PNPase).

Authors:  Danielle L Shepherd; Quincy A Hathaway; Mark V Pinti; Cody E Nichols; Andrya J Durr; Shruthi Sreekumar; Kristen M Hughes; Seth M Stine; Ivan Martinez; John M Hollander
Journal:  J Mol Cell Cardiol       Date:  2017-07-11       Impact factor: 5.000

6.  Chronic kidney disease in children and the role of epigenetics: Future therapeutic trajectories.

Authors:  Samuel N Uwaezuoke; Henrietta U Okafor; Vivian N Muoneke; Odutola I Odetunde; Chioma L Odimegwu
Journal:  Biomed Rep       Date:  2016-10-18

7.  Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca(2+) anomalies.

Authors:  Subat Turdi; Weixia Sun; Yi Tan; Xiaohui Yang; Lu Cai; Jun Ren
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-10       Impact factor: 2.557

Review 8.  The role of epigenetics in the pathology of diabetic complications.

Authors:  Louisa M Villeneuve; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

9.  Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy.

Authors:  Julia M Hum; Linda M O'Bryan; Arun K Tatiparthi; Erica L Clinkenbeard; Pu Ni; Martin S Cramer; Manoj Bhaskaran; Robert L Johnson; Jonathan M Wilson; Rosamund C Smith; Kenneth E White
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

Review 10.  Molecular mechanisms of diabetic cardiomyopathy.

Authors:  Heiko Bugger; E Dale Abel
Journal:  Diabetologia       Date:  2014-01-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.